ADVM - Adverum Biotechnologies Stock Trading

Regenxbio (RGNX) and Adverum (ADVM) are both developing gene therapies for wet AMD. Phase I data is now available that shows both companies may have viable products. It is still very early, and small cohorts make it challenging to evaluate whether RGX-314 or ADVM-022 will be superior. Adverum...

Image source: The Motley Fool. Adverum Biotechnologies, Inc.   (NASDAQ: ADVM) Q1 2020 Earnings Call May 28, 2020 , 4:30 p.m. ET Operator Continue reading

Adverum Biotechnologies, Inc. (ADVM) Q1 2020 Earnings Conference Call May 28, 2020 04:30 PM ET Company Participants Myesha Lacy - Vice President of Investor Relations & Corporate Communications Leone Patterson - President & Chief Executive Officer Aaron Osborne - Chief Me...